carbogen has been researched along with alprostadil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, L; Pothier, DD | 1 |
| Ban, MJ; Kim, JH; Lee, HJ; Lee, JH; Moon, IS; Park, CY; Yang, HS | 1 |
1 review(s) available for carbogen and alprostadil
| Article | Year |
|---|---|
Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss.
Topics: Alprostadil; Carbon Dioxide; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Nafronyl; Oxygen; Randomized Controlled Trials as Topic; Vasodilator Agents | 2009 |
1 other study(ies) available for carbogen and alprostadil
| Article | Year |
|---|---|
Therapeutic effects of carbogen inhalation and lipo-prostaglandin E1 in sudden hearing loss.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Alprostadil; Carbon Dioxide; Female; Hearing Loss, Sudden; Humans; Male; Middle Aged; Oxygen; Retrospective Studies; Treatment Outcome; Young Adult | 2012 |